DocGo Inc. Net Income (Loss) Attributable to Noncontrolling Interest
DocGo Inc. (DCGO) reported Net Income (Loss) Attributable to Noncontrolling Interest of -$2.17 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-17.
Financial Statements › Income Statement › Net Income
us-gaap:NetIncomeLossAttributableToNoncontrollingInterest · last filed 2026-08-17
- DocGo Inc. net income (loss) attributable to noncontrolling interest for the quarter ending 2026-06-30 was -$2.17M.
- DocGo Inc. net income (loss) attributable to noncontrolling interest for the quarter ending 2026-03-31 was -$1.94M.
- DocGo Inc. net income (loss) attributable to noncontrolling interest for the quarter ending 2025-12-31 was -$8.27M.
- DocGo Inc. net income (loss) attributable to noncontrolling interest for the quarter ending 2025-09-30 was -$1.89M.
- DocGo Inc. net income (loss) attributable to noncontrolling interest for fiscal 2025 was -$13.97M.
- DocGo Inc. net income (loss) attributable to noncontrolling interest for fiscal 2024 was -$6.63M, a 307.89% decline from fiscal 2023.
- DocGo Inc. net income (loss) attributable to noncontrolling interest for fiscal 2023 was $3.19M.
- DocGo Inc. net income (loss) attributable to noncontrolling interest for fiscal 2022 was -$3.84M.
| Period end | Net Income (Loss) Attributable to Noncontrolling Interest 3 month | Net Income (Loss) Attributable to Noncontrolling Interest 6 month | Net Income (Loss) Attributable to Noncontrolling Interest 9 month | Net Income (Loss) Attributable to Noncontrolling Interest 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$2.17M 10-Q · filed 2026-08-17 | -$4.11M 10-Q · filed 2026-08-17 | -$12.38M derived: sum of 3 quarters · filed 2026-08-17 | -$14.27M derived: sum of 4 quarters · filed 2026-08-17 |
| 2026-03-31 | -$1.94M 10-Q · filed 2026-08-17 | -$10.21M derived: sum of 2 quarters · filed 2026-08-17 | -$12.10M derived: sum of 3 quarters · filed 2026-08-17 | -$14.23M derived: sum of 4 quarters · filed 2026-08-17 |
| 2025-12-31 | -$8.27M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | -$10.16M derived: sum of 2 quarters · filed 2026-03-16 | -$12.29M derived: sum of 3 quarters · filed 2026-08-17 | -$13.97M 10-K · filed 2026-03-16 |
| 2025-09-30 | -$1.89M 10-Q · filed 2025-11-10 | -$4.02M derived: sum of 2 quarters · filed 2026-08-17 | -$5.70M 10-Q · filed 2025-11-10 | -$10.08M derived: sum of 4 quarters · filed 2026-08-17 |
| 2025-06-30 | -$2.13M 10-Q · filed 2026-08-17 | -$3.81M 10-Q · filed 2026-08-17 | -$8.19M derived: sum of 3 quarters · filed 2026-08-17 | -$9.15M derived: sum of 4 quarters · filed 2026-08-17 |
| 2025-03-31 | -$1.67M 10-Q · filed 2026-08-17 | -$6.06M derived: sum of 2 quarters · filed 2026-08-17 | -$7.01M derived: sum of 3 quarters · filed 2026-08-17 | -$7.68M derived: sum of 4 quarters · filed 2026-08-17 |
| 2024-12-31 | -$4.38M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | -$5.34M derived: sum of 2 quarters · filed 2026-03-16 | -$6.01M derived: sum of 3 quarters · filed 2026-03-16 | -$6.63M 10-K · filed 2026-03-16 |
| 2024-09-30 | -$952.35K 10-Q · filed 2025-11-10 | -$1.62M derived: sum of 2 quarters · filed 2025-11-10 | -$2.25M 10-Q · filed 2025-11-10 | -$1.82M derived: sum of 4 quarters · filed 2026-03-16 |
| 2024-06-30 | -$671.03K 10-Q · filed 2025-11-10 | -$1.30M 10-Q · filed 2025-08-07 | -$872.31K derived: sum of 3 quarters · filed 2026-03-16 | -$1.01M derived: sum of 4 quarters · filed 2026-03-16 |
| 2024-03-31 | -$624.07K 10-Q · filed 2025-11-10 | -$201.28K derived: sum of 2 quarters · filed 2026-03-16 | -$335.96K derived: sum of 3 quarters · filed 2026-03-16 | $3.02M derived: sum of 4 quarters · filed 2026-03-16 |
| 2023-12-31 | $422.79K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $288.11K derived: sum of 2 quarters · filed 2026-03-16 | $3.64M derived: sum of 3 quarters · filed 2026-03-16 | $3.19M 10-K · filed 2026-03-16 |
| 2023-09-30 | -$134.68K 10-Q · filed 2024-11-07 | $3.22M derived: sum of 2 quarters · filed 2024-11-07 | $2.77M 10-Q · filed 2024-11-07 | $1.85M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $3.35M 10-Q · filed 2024-11-07 | $2.90M 10-Q · filed 2024-08-07 | $1.99M derived: sum of 3 quarters · filed 2025-02-27 | $1.30M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | -$453.12K 10-Q · filed 2024-11-07 | -$1.37M derived: sum of 2 quarters · filed 2025-02-27 | -$2.06M derived: sum of 3 quarters · filed 2025-02-27 | -$3.04M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | -$916.29K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | -$1.60M derived: sum of 2 quarters · filed 2025-02-27 | -$2.58M derived: sum of 3 quarters · filed 2025-02-27 | -$3.84M 10-K · filed 2025-02-27 |
| 2022-09-30 | -$687.94K 10-Q · filed 2023-11-06 | -$1.67M derived: sum of 2 quarters · filed 2023-11-06 | -$2.92M 10-Q · filed 2023-11-06 | -$6.21M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | -$979.79K 10-Q · filed 2023-11-06 | -$2.24M 10-Q · filed 2023-08-08 | -$5.52M derived: sum of 3 quarters · filed 2024-02-28 | -$8.23M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | -$1.26M 10-Q · filed 2023-11-06 | -$4.54M derived: sum of 2 quarters · filed 2024-02-28 | -$7.25M derived: sum of 3 quarters · filed 2024-02-28 | -$5.50M derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | -$3.29M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | -$5.99M derived: sum of 2 quarters · filed 2024-02-28 | -$4.24M derived: sum of 3 quarters · filed 2024-02-28 | -$4.56M 10-K · filed 2024-02-28 |
| 2021-09-30 | -$2.71M 10-Q · filed 2022-11-08 | -$957.73K derived: sum of 2 quarters · filed 2022-11-08 | -$1.28M 10-Q · filed 2022-11-08 | |
| 2021-06-30 | $1.75M 10-Q · filed 2022-08-09 | $1.43M 10-Q · filed 2022-08-09 | ||
| 2021-03-31 | -$320.63K 10-Q · filed 2022-05-10 | |||
| 2020-12-31 | -$439.27K 10-K · filed 2022-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |